78788 Federal Register / Vol. 88, No. 220 / Thursday, November 16, 2023 / Notices 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 362–3261, email: 

scott.a.brinks@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0023. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Import/Export Declaration for List I and 

List II Chemicals. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: DEA Forms: 486, 486A. The 

applicable component within the 

Department of Justice is the Drug 

Enforcement Administration, Diversion 

Control Division. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Affected public (Primary): 

Business or other for-profit. Affected 

public (Other): Not-for-profit 

institutions; Federal, State, local, and 

tribal governments. 

Abstract: Section 1018 of the 

Controlled Substances Import and 

Export Act (CSIEA) (21 U.S.C. 971) and 

Title 21 Code of Federal Regulations (21 

CFR) Part 1313 require any persons who 

import, export, or conduct international 

transactions involving list I and list II 

chemicals are required to establish a 

system of recordkeeping and report 

certain information regarding those 

transactions to DEA. The chemicals 

subject to control are used in the 

clandestine manufacture of controlled 

substances. The reports of domestic, 

import, and export regulated 

transactions in listed chemicals are 

submitted electronically through the 

Diversion Control Division secure 

network application. Any person who 

desires to import non-narcotic 

substances in schedules III, IV, and V 

must electronically file their return 

information. Any person who desires to 

export non-narcotic substances in 

schedules III and IV and any other 

substance in schedule V is also required 

to electronically file a controlled 

substances import declaration/ 

controlled substance export invoice. 

5. Obligation to Respond: Mandatory 

per 21 CFR 1313. 

6. Total Estimated Number of 

Respondents: 631. 

7. Estimated Time per Respondent: 11 

minutes for DEA–486 Import, DEA–486 

International, and DEA–486A Import, 

and 12 minutes for DEA–486 Export. 

8. Frequency: 1 for DEA–486 Import 

and DEA–486A Import, 4 for DEA–486 

International, and 77 for DEA–486 

Export. 

9. Total Estimated Annual Time 

Burden: Ex: 4,134 hours. 

10. Total Estimated Annual Other 

Costs Burden: $0. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218 Washington, DC 20530. 

Dated: November 7, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–25326 Filed 11–15–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0013] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Application 

for Permit To Import Controlled 

Substances for Domestic and/or 

Scientific Purposes 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. This proposed 

information collection was previously 

published in the Federal Register on 

September 11, 2023, allowing for a 60- 

day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

December 18, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 362–3261, email: 

scott.a.brinks@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 88, No. 220 / Thursday, November 16, 2023 / Notices 78789 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0013. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 

cannot be for more than three (3) years 

without renewal. The DOJ notes that 

information collection requirements 

submitted to the OMB for existing ICRs 

receive a month-to-month extension 

while they undergo review. 

Overview of This Information 

Collection 

1. Type of Information Collection: 

Extension of a currently approved 

collection. 

2. Title of the Form/Collection: 

Controlled Substances Import/Export 

Declaration. 

3. Agency form number, if any, and 

the applicable component of the 

Department of Justice sponsoring the 

collection: Application for Permit to 

Import Controlled Substances for 

Domestic and/or Scientific Purposes 

Pursuant to 21 U.S.C. 952. 

4. Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Affected public (Primary): 

Business or other for-profit. 

Abstract: Section 1002 of the 

Controlled Substances Import and 

Export Act (CSIEA) (21 U.S.C. 952) and 

Title 21, Code of Federal Regulations 

(21 CFR), Sections 1312.11, 1312.12 and 

1312.13 requires any person who 

desires to import controlled substances 

listed in schedules I or II, any narcotic 

substance listed in schedules III or IV, 

or any non-narcotic substance in 

schedule III which the Administrator 

has specifically designated by regulation 

in section1312.30, or any nonnarcotic 

substance in schedule IV or V which is 

also listed in schedule I or II of the 

Convention on Psychotropic 

Substances, must have an import 

permit. To obtain the permit to import 

controlled substances for domestic and 

or scientific purposes, an application for 

the permit must be made to DEA on 

DEA Form 357. 

5. Obligation to Respond: Mandatory 

per 21 CFR 1312.11 

6. Total Estimated Number of 

Respondents: 124. 

7. Estimated Time per Respondent: 

0.26 minutes. 

8. Frequency: 9. 

9. Total Estimated Annual Time 

Burden: 264.35 hours. 

10. Total Estimated Annual Other 

Costs Burden: $0. 

If additional information is required, 

contact: Darwin Arceo, Department 

Clearance Officer, Policy and Planning 

Staff, Justice Management Division, 

United States Department of Justice, 

Two Constitution Square, 145 N Street 

NE, 4W–218 Washington, DC 20530. 

Dated: November 8, 2023. 

Darwin Arceo, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2023–25325 Filed 11–15–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1117–0004] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Application 

for Permit To Export Controlled 

Substances, Application for Permit To 

Export Controlled Substances for 

Subsequent Reexport 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Drug Enforcement 

Administration (DEA), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. This proposed 

information collection was previously 

published in the Federal Register on 

September 11, 2023, allowing for a 60- 

day comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

December 18, 2023. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Scott A. Brinks, Regulatory 

Drafting and Policy Support Section, 

Drug Enforcement Administration; 

Mailing Address: 8701 Morrissette 

Drive, Springfield, Virginia 22152; 

Telephone: (571) 362–3261, email: 

scott.a.brinks@dea.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and/or 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Written comments and 

recommendations for this information 

collection should be submitted within 

30 days of the publication of this notice 

on the following website 

www.reginfo.gov/public/do/PRAMain. 

Find this particular information 

collection by selecting ‘‘Currently under 

30-day Review—Open for Public 

Comments’’ or by using the search 

function and entering either the title of 

the information collection or the OMB 

Control Number 1117–0004. This 

information collection request may be 

viewed at www.reginfo.gov. Follow the 

instructions to view Department of 

Justice, information collections 

currently under review by OMB. 

DOJ seeks PRA authorization for this 

information collection for three (3) 

years. OMB authorization for an ICR 


lotter on DSK11XQN23PROD with NOTICES1